Back

Antifibrotic drugs: the journey to prime time

12 April 2026 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Pharmacological treatment for atrial fibrillation Arrhythmias, General EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Shingo Matsumoto

Tokai University, Tokyo (Japan)

3 More presentations in this session

Presentation thumbnail
SGLT2 inhibitors: a new era in atrial fibrillation prevention?
Professor D. Linz (Maastricht, NL)
Slides
Presentation thumbnail
The emerging promise of GLP-1 receptor agonists
Professor V. Caso (Perugia, IT)
Slides
Presentation thumbnail
Anti-hypertensive agents: is there a benefit beyond lowering blood pressure?
Professor M. Rienstra (Groningen, NL)
Slides

Access the full session

Session thumbnail
Pharmacological treatment for atrial fibrillation

The Event

Event poster

EHRA 2026

12 April - 14 April 2026

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources